Clinical syndromes across the FTD-ALS-atypical parkinsonism spectrum have been reported, and so mutations in TBK1 should always be kept in mind with these presentations, particularly in families where there are multiple different phenotypes. This evidence concerns the gene TBK1 and amyotrophic lateral sclerosis.